Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26Hiroyuki Gatanaga, Shinichi Oka, Katsuya Fujimoto et al.|Clinical Infectious Diseases|2007Cited by 222
Strong Ability of Nef-Specific CD4<sup>+</sup>Cytotoxic T Cells To Suppress Human Immunodeficiency Virus Type 1 (HIV-1) Replication in HIV-1-Infected CD4<sup>+</sup>T Cells and MacrophagesNan Zheng, Masafumi Takiguchi, Mamoru Fujiwara et al.|Journal of Virology|2009Cited by 45
Selection of escape mutant by HLA‐C‐restricted HIV‐1 Pol‐specific cytotoxic T lymphocytes carrying strong ability to suppress HIV‐1 replicationKazutaka Honda, Masafumi Takiguchi, Shinichi Oka et al.|European Journal of Immunology|2010Cited by 28